Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2716

LikeLikedUnlike

Episodes 91-105 of 739

Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
MinuteCE®
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
- James M. Cleary, MD, PhD
  Peer
0.50 program credits
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
- James M. Cleary, MD, PhD
  Peer
0.50 program credits
Beyond GDMT: Timely Consideration of Barostim in Heart Failure
CME/CE
Beyond GDMT: Timely Consideration of Barostim in Heart Failure
- Patrick J. McCann, MD
  Peer
- Rajeev Mohan, MD
  Peer
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
CME/CE
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
- Jürgen Floege, MD
  Peer
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
- Joseph F. Goldberg, MD
  Peer
1.00 credits
MinuteCE®
Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025  
- Luis Paz-Ares, MD, PhD
  Peer
- Lauren A. Byers, MD
  Peer
0.50 credits 6 episodes
advertisement
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
MinuteCE®
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
- Lauren A. Byers, MD
  Peer
0.50 program credits
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
- Luis Paz-Ares, MD, PhD
  Peer
- Lauren A. Byers, MD
  Peer
0.50 program credits
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
MinuteCE®
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
- Luis Paz-Ares, MD, PhD
  Peer
- Lauren A. Byers, MD
  Peer
0.50 program credits
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
MinuteCE®
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
- Luis Paz-Ares, MD, PhD
  Peer
0.50 program credits
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
- Luis Paz-Ares, MD, PhD
  Peer
- Lauren A. Byers, MD
  Peer
0.50 program credits
Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
MinuteCE®
Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
- Luis Paz-Ares, MD, PhD
  Peer
- Lauren A. Byers, MD
  Peer
0.50 program credits
advertisement
MinuteCE®
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
- James Burton, DM, FRCP
  Peer
- Javed Butler, MD
  Peer
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Patrick Rossignol, MD, PhD
  Peer
1.00 credits 9 episodes
The Critical Interplay: CKD, HF, and Hyperkalemia
MinuteCE®
The Critical Interplay: CKD, HF, and Hyperkalemia
- James Burton, DM, FRCP
  Peer
- Javed Butler, MD
  Peer
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Patrick Rossignol, MD, PhD
  Peer
1.00 program credits
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
MinuteCE®
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Javed Butler, MD, MPH, MBA
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended